Measure the level of prostate-specific antigen (PSA) in your blood, plus free/total PSA ratio to powerfully predict the risk of future prostate cancer morbidity or other noncancerous prostate conditions such as enlarged prostate (benign prostatic hyperplasia) or inflammation of the prostate (prostatitis).